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But What is the Science?
This classic question of Dr. Francois Abboud, past Presi-
dent of the American Heart Association and Director of the
Cardiovascular Research Center at the University of Iowa
Hospitals and Clinics, had to do with modalities, including
imaging modalities, that neither contributed to our under-
standing of cardiovascular pathophysiology nor therapeuti-
cally improved cardiovascular pathophysiology.
See page 1623
Clinical diagnostic ultrasound (USD) (including cardio-
vascular) has been with us for approximately four decades.
The imaging aspects of USD have significantly contributed
to our knowledge of cardiovascular disease. Diagnostic USD
has been used to answer questions concerning the timing of
cardiac valve replacement (1,2); helped in understanding the
pathophysiology of cardiac diseases, such as idiopathic
hypertrophic subaortic stenosis (3); helped us understand
how structural alterations occur in coronary and peripheral
arteries with developing atherosclerosis (4,5); and helped to
improve our understanding of coronary flow alterations in
human atherosclerosis (6). By utilizing the physical princi-
ples of USD scattering, new agents have been developed
that improve cardiovascular structural characterization,
myocardial perfusion, and targeted molecular imaging of
atherosclerosis using diagnostic USD (7,8). These are just a
few of the thousands of applications that diagnostic USD
has provided.
Although USD has matured as an imaging modality that
is reliable and can be used to answer cardiovascular ques-
tions, it has much more potential. The science of USD, in
addition to its imaging capability, also lies in its biologic
effects.
The physical effects of ultrasound have been studied in
vitro and in vivo in animal models and reviewed by Fowlkes
and Holland (9,10). The physical effects of USD can be
classified in two principal groups: 1) thermal and 2) me-
chanical. The effect of elevated temperature on tissue has
been recognized, and the effects due to USD are not
substantially different from those of any other localized heat
source. The mechanical effects of USD include: 1) acoustic
radiation forces on the structures within the body at both
macroscopic and microscopic levels, resulting in exerted
pressure and torque; 2) acoustically induced flow, or stream-
ing; and 3) nucleation and pulsation of bubbles, or cavita-
tion. The latter has been further utilized by developing
therapeutic microbubbles, which encapsulate agents for
targeted drug delivery and gene transfection into living cells
upon exposure to USD (11–21). This application stems
from the finding that the permeability of cell walls for large
molecules (drugs and genes) is increased in the presence of
USD and microbubbles (19).
In this issue of the Journal, Miyamoto et al. (21) expand
the use of USD by demonstrating that low-level USD can
cause vascular smooth muscle relaxation and arterial dilation
in the coronary bed. Changes were measured by both
intravascular USD and coronary angiography. Their results
show that low-level USD has a similar effect to that of
nitroglycerin in causing coronary artery vasodilation. Impor-
tantly, the effect is generalized, i.e., the transducer does not
need to be directly over the coronary artery in question for
vasodilation to occur; no significant temperature changes
were noted; and limited pathologic analysis demonstrated a
lack of gross changes in tissue structure over the USD
exposure period. These data are important.
Why does this phenomenon occur? Ultrasound is known
to have mechanical effects on tissue, both directly and by
increasing shear stress on vascular tissues (acoustic radia-
tion). Ultrasound can also cause cavitation effects when gas
contrast agents, air, or similar interfaces are present. Al-
though speculative in this study, USD most likely increases
shear stress on endothelial cells, releasing nitric oxide, with
resultant vasodilation. This mechanism is supported by
other studies that demonstrate that the vasodilatory effects
of USD can be blocked by the nitric oxide synthase inhibitor
NG-nitro-L-arginine methyl ester (22,23).
Similar to this study, the biologic effects of USD that are
actively being investigated include all mechanical subtypes:
radiation, streaming, and cavitation. These mechanical ef-
fects are intensively being investigated in the vascular and
thrombolytic fields. Kilohertz frequency USD has been
found to disrupt peripheral arterial and venous thrombi in
animal models (24–26). The laboratory that presents the
current article in the Journal has pioneered the use of the
mechanical effects of USD to disrupt arterial atherosclerosis
(27,28). Thrombolytic investigators have utilized the bio-
logic effects of USD to enhance thrombolytics in peripheral
thrombi and stroke models (29–37). Proposed mechanisms
of USD-enhanced thrombolysis include: acoustic streaming
alone, without cavitational effects; acceleration of fibrinoly-
sis by increasing transport of reactants through a cavitation-
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related mechanism; or radiation effects that would alter the
structure of the thrombus itself, allowing better penetration
of lytic agents.
Of importance in the drug and gene therapeutic arena is
the use of USD cavitational effects to enhance drug and
gene delivery to pathologic cells for directed regional ther-
apeutics and gene transfection (11–20). Drug and gene
delivery can be enhanced more than 10-fold without dele-
terious consequences to the cell by the addition of thera-
peutic USD. These and other investigators are actively
researching trapping the physical effects of USD to advance
cardiovascular therapeutics.
So what is the utility and science of the study in the
Journal by Miyamoto et al. (21)? Two utilities immediately
come to mind. This technique may be used with angiogra-
phy—especially quantitative coronary angiography—in bet-
ter determining the physiologic severity of coronary steno-
ses. By giving therapeutic transcutaneous USD before and
after angiography, areas of physiologic stenosis could be
unmasked that were not apparent at the time of angiogra-
phy. As the effect is widespread over the coronary arterial
tree, selective intracoronary nitroglycerin might not be
required.
Transthoracic USD could directly enhance intracoronary
thrombolysis or, if given in conjunction with enhanced
echogenic therapeutics, improve thrombolysis or drug and
gene delivery. These would occur by both acoustic radiation
forces and cavitational effects. As the stroke literature has
demonstrated that these frequencies of USD can penetrate
the skull and accelerate thrombolysis (32,33), the use of
transthoracic USD for coronary interventions seems realistic.
So, Dr. Abboud: “This Is the Science of Ultrasound.”
A novel, noninvasive methodology to evaluate coronary
vascular flow/physiology has been demonstrated. By har-
nessing the physical effects of USD, we can physiologically
evaluate and therapeutically affect vascular and biologic
tissue. The door is now open to expand USD beyond the
arena of diagnostic imaging.
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